Elicio Therapeutics
Latest round
- Series B
Last raised
- Oct 2019
Total raised
- $36M
Investors
- 5
About Elicio Therapeutics
Elicio Therapeutics, Inc.Founded in 2011 in Boston, US, Elicio Therapeutics, Inc. focuses on developing innovative immunotherapies.02 mn.Elicio Therapeutics specializes in developing lymph node-targeted immunotherapies aimed at enhancing immune responses against aggressive cancers, notably pancreatic ductal adenocarcinoma (PDAC). Utilizing its proprietary AMP platform, the company creates next-generation vaccines, immunomodulators, and adjuvants, designed to activate T cells and amplify immune responses.Elicio Therapeutics generates revenue through partnerships with healthcare institutions and collaborative agreements for its immunotherapy products. These agreements facilitate the acquisition of therapies through direct purchases or clinical trial contracts. Key products such as ELI-002, ELI-007, and ELI-008 are central to Elicio's revenue strategy, emphasizing the innovative solutions offered in immuno-oncology.Elicio Therapeutics is focused on expanding its product line and geographic reach. The company is working on upcoming releases of its immunotherapy products and plans to enter new markets by targeting European and Asian healthcare sectors within the next two years., although the financial terms were not disclosed.
Who invested in Elicio Therapeutics
5 investors across 3 rounds
See all investors in Elicio Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Elicio Therapeutics
Who invested in Elicio Therapeutics?
Elicio Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elicio Therapeutics raised?
Elicio Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Elicio Therapeutics last raise money?
Elicio Therapeutics's most recent round on record is a Series B, in Oct 2019.
What does Elicio Therapeutics do?
Elicio Therapeutics is a biotechnology company.
Where is Elicio Therapeutics headquartered?
Elicio Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Elicio Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Elicio Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Elicio Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.